Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series.
Stabile A, Barletta F, Motterle G, Pellegrino F, Sorce G, Mazzone E, Scuderi S, Cirulli GO, Cucchiara V, Esposito A, Gandaglia G, Fossati N, De Cobelli F, Montorsi F, Karnes RJ, Briganti A. Stabile A, et al. Among authors: pellegrino f. Prostate Cancer Prostatic Dis. 2021 Dec;24(4):1137-1142. doi: 10.1038/s41391-021-00371-y. Epub 2021 May 3. Prostate Cancer Prostatic Dis. 2021. PMID: 33941867
Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer.
Gandaglia G, Fossati N, Zaffuto E, Bandini M, Dell'Oglio P, Bravi CA, Fallara G, Pellegrino F, Nocera L, Karakiewicz PI, Tian Z, Freschi M, Montironi R, Montorsi F, Briganti A. Gandaglia G, et al. Among authors: pellegrino f. Eur Urol. 2017 Oct;72(4):632-640. doi: 10.1016/j.eururo.2017.03.049. Epub 2017 Apr 12. Eur Urol. 2017. PMID: 28412062
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis.
Mazzone E, Stabile A, Pellegrino F, Basile G, Cignoli D, Cirulli GO, Sorce G, Barletta F, Scuderi S, Bravi CA, Cucchiara V, Fossati N, Gandaglia G, Montorsi F, Briganti A. Mazzone E, et al. Among authors: pellegrino f. Eur Urol Oncol. 2021 Oct;4(5):697-713. doi: 10.1016/j.euo.2020.12.004. Epub 2020 Dec 25. Eur Urol Oncol. 2021. PMID: 33358543 Review.
Neoadjuvant and adjuvant immunotherapy in renal cell carcinoma.
Martini A, Fallara G, Pellegrino F, Cirulli GO, Larcher A, Necchi A, Montorsi F, Capitanio U. Martini A, et al. Among authors: pellegrino f. World J Urol. 2021 May;39(5):1369-1376. doi: 10.1007/s00345-020-03550-z. Epub 2021 Jan 1. World J Urol. 2021. PMID: 33386494 Review.
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era?
Mazzone E, Stabile A, Sorce G, Pellegrino F, Barletta F, Motterle G, Scuderi S, Cirulli GO, Cucchiara V, Brembilla G, Esposito A, Gandaglia G, Fossati N, De Cobelli F, Montorsi F, Karnes RJ, Guccini I, Briganti A. Mazzone E, et al. Among authors: pellegrino f. Urol Oncol. 2021 Nov;39(11):784.e1-784.e9. doi: 10.1016/j.urolonc.2021.03.013. Epub 2021 Apr 15. Urol Oncol. 2021. PMID: 33865687
Association between Lesion Location and Oncologic Outcomes after Focal Therapy for Localized Prostate Cancer Using Either High Intensity Focused Ultrasound or Cryotherapy.
Stabile A, Sanchez-Salas R, Tourinho-Barbosa R, Macek P, Pellegrino F, Gandaglia G, Moschini M, Cathala N, Mombet A, Montorsi F, Briganti A, Cathelineau X. Stabile A, et al. Among authors: pellegrino f. J Urol. 2021 Sep;206(3):638-645. doi: 10.1097/JU.0000000000001787. Epub 2021 Apr 23. J Urol. 2021. PMID: 33890485
How to Select the Optimal Candidates for Renal Mass Biopsy.
Martini A, Larcher A, Bravi CA, Capogrosso P, Falagario UG, Fallara G, Pellegrino F, Muttin F, Re C, Briganti A, Salonia A, Bertini R, Montorsi F, Capitanio U; Young Academic Urologists working groups on robotic surgery and kidney cancer of the European Association of Urology. Martini A, et al. Among authors: pellegrino f. Eur Urol Oncol. 2021 Jun;4(3):506-509. doi: 10.1016/j.euo.2020.10.001. Epub 2020 Oct 21. Eur Urol Oncol. 2021. PMID: 34074486
Reply by Authors.
Stabile A, Sanchez-Salas R, Tourinho-Barbosa R, Macek P, Pellegrino F, Gandaglia G, Moschini M, Cathala N, Mombet A, Montorsi F, Briganti A, Cathelineau X. Stabile A, et al. Among authors: pellegrino f. J Urol. 2021 Sep;206(3):645. doi: 10.1097/JU.0000000000001787.02. Epub 2021 Jun 15. J Urol. 2021. PMID: 34126782 No abstract available.
A mechanistic insight into the anti-metastatic role of the prostate specific antigen.
Pellegrino F, Coghi A, Lavorgna G, Cazzaniga W, Guazzoni E, Locatelli I, Villa I, Bolamperti S, Finocchio N, Alfano M, Lucianò R, Briganti A, Montorsi F, Salonia A, Cavarretta I. Pellegrino F, et al. Transl Oncol. 2021 Nov;14(11):101211. doi: 10.1016/j.tranon.2021.101211. Epub 2021 Aug 26. Transl Oncol. 2021. PMID: 34455373 Free PMC article.
247 results